Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 157 results
Author Title [ Year(Desc)]
Filters: Author is Aplenc, Richard  [Clear All Filters]
2012
Marsac ML, Hildenbrand AK, Clawson K, et al. "Acceptability and feasibility of family use of The Cellie Cancer Coping Kit." Support Care Cancer. 2012;20(12):3315-24.
Sepe DM, McWilliams T, Chen J, et al. "Germline genetic variation and treatment response on CCG-1891." Pediatr Blood Cancer. 2012;58(5):695-700.
Meshinchi S, Hunger SP, Aplenc R, Adamson PC, Jessup JM. "Lessons learned from the investigational device exemption review of Children's Oncology Group trial AAML1031." Clin. Cancer Res.. 2012;18(6):1547-54.
Aplenc R, Fisher BT, Huang YS, et al. "Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the COG." Pharmacoepidemiol Drug Saf. 2012;21 Suppl 2:37-43.
Lambert MP, Reznikov A, Grubbs A, et al. "Platelet factor 4 platelet levels are inversely correlated with steady-state platelet counts and with platelet transfusion needs in pediatric leukemia patients." J. Thromb. Haemost.. 2012;10(7):1442-6.
Sung L, Aplenc R, Alonzo TA, Gerbing RB, Gamis AS. "Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children's Oncology Group." Haematologica. 2012;97(11):1770-3.
Lehrnbecher T, Aplenc R, Pereira FRivas, et al. "Variations in non-pharmacological anti-infective measures in childhood leukemia--results of an international survey." Haematologica. 2012;97(10):1548-52.
2013
Kavcic M, Fisher BT, Torp K, et al. "Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children's hospitals in the United States using an administrative database." Pediatr Blood Cancer. 2013;60(3):508-11.
Grupp SA, Kalos M, Barrett D, et al. "Chimeric antigen receptor-modified T cells for acute lymphoid leukemia." N. Engl. J. Med.. 2013;368(16):1509-18.
Teachey DT, Rheingold SR, Maude SL, et al. "Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy." Blood. 2013;121(26):5154-7.
Walker DM, Fisher BT, Seif AE, et al. "Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database." Pediatr Blood Cancer. 2013;60(4):616-20.
Sung L, Aplenc R, Alonzo TA, Gerbing RB, Lehrnbecher T, Gamis AS. "Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group." Blood. 2013;121(18):3573-7.
Puumala SE, Ross JA, Aplenc R, Spector LG. "Epidemiology of childhood acute myeloid leukemia." Pediatr Blood Cancer. 2013;60(5):728-33.
Meyer NJ, Feng R, Li M, et al. "IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist." Am. J. Respir. Crit. Care Med.. 2013;187(9):950-9.
Kavcic M, Fisher BT, Li Y, et al. "Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States." Cancer. 2013;119(10):1916-23.
Kavcic M, Fisher BT, Seif AE, et al. "Leveraging administrative data to monitor rituximab use in 2875 patients at 42 freestanding children's hospitals across the United States." J. Pediatr.. 2013;162(6):1252-8, 1258.e1.
Johnston DL, Nagarajan R, Caparas M, et al. "Reasons for non-completion of health related quality of life evaluations in pediatric acute myeloid leukemia: a report from the Children's Oncology Group." PLoS ONE. 2013;8(9):e74549.
de Blank P, Zaoutis TE, Fisher BT, Troxel AB, Kim J, Aplenc R. "Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer." J. Pediatr.. 2013;163(3):699-705.e1.
Kang TI, Hexem K, Localio R, Aplenc R, Feudtner C. "The use of palliative chemotherapy in pediatric oncology patients: a national survey of pediatric oncologists." Pediatr Blood Cancer. 2013;60(1):88-94.
Fisher BT, Gerber JS, Leckerman KH, et al. "Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemia." Leuk. Lymphoma. 2013;54(8):1633-9.

Pages